Terrestrial radio needs to understand and vet the streaming tech properly, similar to the AM to FM transition, Greg Ogonowski ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with ...

Corcept Therapeutics (CORT) leverages Korlym’s commercial success in hypercortisolism, generating $559.3M in nine-month 2025 ...

Erich Rajkovic Erich Rajkovic - new Eleva CBO Freiburg im Breisgau, Germany – January 8, 2026 – Eleva, a pioneer in ...

As these systems evolve, I believe therapeutic ultrasound is poised to become medicine's next general-purpose platform.

I don't know how many people of my cohort were listening to Janis Ian alone on headphones in their bedrooms when her album ...

Heart-healthy breakfasts that aren't eggs include fiber, healthy fats, and protein to support cholesterol levels, blood pressure, and overall cardiovascular health.

Bringing Decades of Successful Biotech Company Growth, Financing, IPO and M&A ExpertiseNORFOLK, Va.--(BUSINESS WIRE)--ReAlta ...

Bright Minds Biosciences (DRUG) stays a Strong Buy after Phase 2 BMB-101 seizure-reduction data; see 2026 catalysts, ...

Even if fly-halves are considered to be the brainiest members of any team – a cliché that line-out callers might contest – ...

We are thrilled to welcome Arjun and Cyndi to the Compass team. They are highly accomplished leaders with decades of commercial and clinical development experience,” said Thomas Schuetz, MD, PhD, CEO ...

As of Friday, January 02, Marvell Technology, Inc.’s MRVL share price has surged by 5.25%, which has investors questioning if this is right time to sell.